Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Reprinted with AIS Health permission from the November 2024 issue of Radar on Specialty Pharmacy

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Prime Therapeutics offers holistic and data-driven solutions to manage drug costs and simplify the patient experience for those with hemophilia and other blood disorders

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”

Prime celebrates 25th anniversary, and Magellan Rx celebrates 10th anniversary

AIS Health

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”